• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于代理的动脉粥样硬化血管中血管成形术和裸金属支架植入反应模型。

An agent-based model of the response to angioplasty and bare-metal stent deployment in an atherosclerotic blood vessel.

作者信息

Curtin Antonia E, Zhou Leming

机构信息

Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.

Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America; Department of Health Information Management, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.

出版信息

PLoS One. 2014 Apr 14;9(4):e94411. doi: 10.1371/journal.pone.0094411. eCollection 2014.

DOI:10.1371/journal.pone.0094411
PMID:24732072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3986389/
Abstract

PURPOSE

While animal models are widely used to investigate the development of restenosis in blood vessels following an intervention, computational models offer another means for investigating this phenomenon. A computational model of the response of a treated vessel would allow investigators to assess the effects of altering certain vessel- and stent-related variables. The authors aimed to develop a novel computational model of restenosis development following an angioplasty and bare-metal stent implantation in an atherosclerotic vessel using agent-based modeling techniques. The presented model is intended to demonstrate the body's response to the intervention and to explore how different vessel geometries or stent arrangements may affect restenosis development.

METHODS

The model was created on a two-dimensional grid space. It utilizes the post-procedural vessel lumen diameter and stent information as its input parameters. The simulation starting point of the model is an atherosclerotic vessel after an angioplasty and stent implantation procedure. The model subsequently generates the final lumen diameter, percent change in lumen cross-sectional area, time to lumen diameter stabilization, and local concentrations of inflammatory cytokines upon simulation completion. Simulation results were directly compared with the results from serial imaging studies and cytokine levels studies in atherosclerotic patients from the relevant literature.

RESULTS

The final lumen diameter results were all within one standard deviation of the mean lumen diameters reported in the comparison studies. The overlapping-stent simulations yielded results that matched published trends. The cytokine levels remained within the range of physiological levels throughout the simulations.

CONCLUSION

We developed a novel computational model that successfully simulated the development of restenosis in a blood vessel following an angioplasty and bare-metal stent deployment based on the characteristics of the vessel cross-section and stent. A further development of this model could ultimately be used as a predictive tool to depict patient outcomes and inform treatment options.

摘要

目的

虽然动物模型被广泛用于研究血管介入后再狭窄的发展,但计算模型为研究这一现象提供了另一种手段。经治疗血管反应的计算模型将使研究人员能够评估改变某些血管和支架相关变量的影响。作者旨在使用基于智能体的建模技术,开发一种新型的计算模型,用于模拟动脉粥样硬化血管在血管成形术和裸金属支架植入后再狭窄的发展过程。所提出的模型旨在展示机体对干预的反应,并探索不同的血管几何形状或支架排列如何影响再狭窄的发展。

方法

该模型在二维网格空间上创建。它利用术后血管腔直径和支架信息作为输入参数。模型的模拟起点是血管成形术和支架植入术后的动脉粥样硬化血管。模型随后在模拟完成时生成最终管腔直径、管腔横截面积的变化百分比、管腔直径稳定所需时间以及炎症细胞因子的局部浓度。将模拟结果与相关文献中动脉粥样硬化患者的系列成像研究结果和细胞因子水平研究结果直接进行比较。

结果

最终管腔直径结果均在比较研究中报告的平均管腔直径的一个标准差范围内。重叠支架模拟产生的结果与已发表的趋势相符。在整个模拟过程中,细胞因子水平保持在生理水平范围内。

结论

我们开发了一种新型计算模型,该模型基于血管横截面和支架的特征,成功模拟了血管成形术和裸金属支架植入后血管再狭窄的发展过程。该模型的进一步发展最终可作为一种预测工具,用于描述患者的预后并为治疗方案提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9792/3986389/acf99317542f/pone.0094411.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9792/3986389/8a468c583b54/pone.0094411.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9792/3986389/069c1605d40a/pone.0094411.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9792/3986389/75b5773e2c00/pone.0094411.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9792/3986389/10a512f611f9/pone.0094411.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9792/3986389/2989c018c619/pone.0094411.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9792/3986389/acf99317542f/pone.0094411.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9792/3986389/8a468c583b54/pone.0094411.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9792/3986389/069c1605d40a/pone.0094411.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9792/3986389/75b5773e2c00/pone.0094411.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9792/3986389/10a512f611f9/pone.0094411.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9792/3986389/2989c018c619/pone.0094411.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9792/3986389/acf99317542f/pone.0094411.g006.jpg

相似文献

1
An agent-based model of the response to angioplasty and bare-metal stent deployment in an atherosclerotic blood vessel.一种基于代理的动脉粥样硬化血管中血管成形术和裸金属支架植入反应模型。
PLoS One. 2014 Apr 14;9(4):e94411. doi: 10.1371/journal.pone.0094411. eCollection 2014.
2
INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.OCT 评价药物涂层球囊与金属裸支架治疗初发冠状动脉病变的内膜增生(IN-PACT CORO):一项随机对照试验的研究方案。
Trials. 2012 May 6;13:55. doi: 10.1186/1745-6215-13-55.
3
Location-Specific Comparison Between a 3D In-Stent Restenosis Model and Micro-CT and Histology Data from Porcine In Vivo Experiments.3D支架内再狭窄模型与猪体内实验的显微CT及组织学数据的特定位置比较
Cardiovasc Eng Technol. 2019 Dec;10(4):568-582. doi: 10.1007/s13239-019-00431-4. Epub 2019 Sep 17.
4
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).药物洗脱球囊与依维莫司洗脱支架治疗金属裸支架内再狭窄的随机对照研究:RIBS V 临床试验(金属裸支架内再狭窄:紫杉醇洗脱球囊与依维莫司洗脱支架)。
J Am Coll Cardiol. 2014 Apr 15;63(14):1378-86. doi: 10.1016/j.jacc.2013.12.006. Epub 2014 Jan 8.
5
Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.经皮冠状动脉介入治疗器械再狭窄倾向的差异。球囊血管成形术、定向旋切术、支架植入术和准分子激光血管成形术的定量血管造影比较。CARPORT、MERCATOR、MARCATOR、PARK和BENESTENT试验组。
Eur Heart J. 1995 Oct;16(10):1331-46. doi: 10.1093/oxfordjournals.eurheartj.a060740.
6
Simulation of a balloon expandable stent in a realistic coronary artery-Determination of the optimum modelling strategy.模拟真实冠状动脉中的球囊扩张支架-确定最佳建模策略。
J Biomech. 2010 Aug 10;43(11):2126-32. doi: 10.1016/j.jbiomech.2010.03.050. Epub 2010 May 8.
7
Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.切割球囊联合紫杉醇洗脱球囊治疗支架内再狭窄。
Arch Cardiovasc Dis. 2013 Feb;106(2):79-85. doi: 10.1016/j.acvd.2012.10.004. Epub 2013 Jan 30.
8
9
Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.紫杉醇涂层球囊联合裸金属支架对再狭窄和内皮功能的影响:与药物洗脱支架和裸金属支架的比较。
Catheter Cardiovasc Interv. 2014 Aug 1;84(2):323-31. doi: 10.1002/ccd.25184. Epub 2013 Sep 30.
10
Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.经导管载液紫杉醇用于预防支架植入后 native coronary artery lesions 的再狭窄。
Circ Cardiovasc Interv. 2009 Aug;2(4):294-301. doi: 10.1161/CIRCINTERVENTIONS.108.827865.108.827865. Epub 2009 Jul 22.

引用本文的文献

1
A predictive multiscale model of in-stent restenosis in femoral arteries: linking haemodynamics and gene expression with an agent-based model of cellular dynamics.一种预测性的股动脉支架内再狭窄多尺度模型:将血液动力学和基因表达与基于代理的细胞动力学模型联系起来。
J R Soc Interface. 2022 Mar;19(188):20210871. doi: 10.1098/rsif.2021.0871. Epub 2022 Mar 30.
2
Agent-based spatiotemporal simulation of biomolecular systems within the open source MASON framework.基于智能体的生物分子系统在开源MASON框架内的时空模拟。
Biomed Res Int. 2015;2015:769471. doi: 10.1155/2015/769471. Epub 2015 Mar 22.

本文引用的文献

1
Heart disease and stroke statistics--2014 update: a report from the American Heart Association.《2014年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2014 Jan 21;129(3):e28-e292. doi: 10.1161/01.cir.0000441139.02102.80. Epub 2013 Dec 18.
2
Comparison of triple anti-platelet therapy and dual anti-platelet therapy in patients with acute myocardial infarction who had no-reflow phenomenon during percutaneous coronary intervention.比较经皮冠状动脉介入治疗中无复流现象的急性心肌梗死患者的三联抗血小板治疗与双联抗血小板治疗。
Circ J. 2013;77(12):2973-81. doi: 10.1253/circj.cj-13-0594. Epub 2013 Aug 29.
3
Clinical outcomes, health resource use, and cost in patients with early versus late dual or triple anti-platelet treatment for acute coronary syndrome.
急性冠脉综合征患者早期双联或三联抗血小板治疗与晚期双联或三联抗血小板治疗的临床结局、卫生资源利用和成本。
Am J Cardiovasc Drugs. 2013 Aug;13(4):273-83. doi: 10.1007/s40256-013-0026-3.
4
Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement.第一代药物洗脱支架置入术后晚期及极晚期支架血栓形成的病理病因
Thrombosis. 2012;2012:608593. doi: 10.1155/2012/608593. Epub 2012 Nov 21.
5
Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry.药物洗脱支架治疗患者长期双联抗血小板治疗的获益:来自 NHLBI 动态注册研究。
Am J Cardiol. 2013 Feb 15;111(4):486-92. doi: 10.1016/j.amjcard.2012.10.030. Epub 2012 Dec 1.
6
Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation.药物洗脱支架植入术后,两年与一年双联抗血小板治疗在降低极晚期支架血栓形成风险方面的有效性。
J Tehran Heart Cent. 2012 Spring;7(2):47-52. Epub 2012 May 31.
7
Computational models of epilepsy.癫痫的计算模型。
Seizure. 2012 Dec;21(10):748-59. doi: 10.1016/j.seizure.2012.08.012. Epub 2012 Sep 18.
8
Dual anti-platelet therapy in patients with G6PD deficiency after percutaneous coronary intervention.
Int J Cardiol. 2013 May 10;165(2):380-2. doi: 10.1016/j.ijcard.2012.08.024. Epub 2012 Sep 11.
9
Very late thrombosis of a paclitaxel-eluting stent after 72 months in a patient on dual anti-platelet therapy.
Cardiovasc J Afr. 2012 Apr 12;23(3):e9-11. doi: 10.5830/CVJA-2011-022.
10
A comparative study of restenosis rates in bare metal and drug-eluting stents.裸金属支架与药物洗脱支架再狭窄率的对比研究。
Int J Angiol. 2010 Summer;19(2):e66-72. doi: 10.1055/s-0031-1278368.